ADVANZ PHARMA UK AND IRELAND LIMITED
Company number 09793586
- Company Overview for ADVANZ PHARMA UK AND IRELAND LIMITED (09793586)
- Filing history for ADVANZ PHARMA UK AND IRELAND LIMITED (09793586)
- People for ADVANZ PHARMA UK AND IRELAND LIMITED (09793586)
- More for ADVANZ PHARMA UK AND IRELAND LIMITED (09793586)
| Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
|---|---|---|---|
| 20 Nov 2024 | AAMD | Amended full accounts made up to 31 December 2023 | |
| 09 Oct 2024 | CS01 | Confirmation statement made on 30 September 2024 with no updates | |
| 27 Sep 2024 | AA | Total exemption full accounts made up to 31 December 2023 | |
| 26 Mar 2024 | AP01 | Appointment of Mr Nicholas Ettery as a director on 23 February 2024 | |
| 06 Mar 2024 | TM01 | Termination of appointment of Giancarlo Notarianni as a director on 23 February 2024 | |
| 08 Jan 2024 | AA | Full accounts made up to 31 December 2022 | |
| 05 Oct 2023 | CS01 | Confirmation statement made on 30 September 2023 with no updates | |
| 16 Aug 2023 | PSC05 | Change of details for Mercury Pharma Group Limited as a person with significant control on 1 August 2023 | |
| 03 Aug 2023 | CH01 | Director's details changed for Mr Simon Tucker on 31 July 2023 | |
| 03 Aug 2023 | CH01 | Director's details changed for Mr Vikram Laxman Kamath on 31 July 2023 | |
| 03 Aug 2023 | CH01 | Director's details changed for Mr Francisco Javier Barcelo Sanchez on 31 July 2023 | |
| 02 Aug 2023 | CH01 | Director's details changed for Mr Vikram Laxman Kamath on 1 October 2022 | |
| 01 Aug 2023 | AD01 | Registered office address changed from Capital House 85 King William Street London EC4N 7BL England to Dashwood House 69 Old Broad Street London EC2M 1QS on 1 August 2023 | |
| 04 May 2023 | AA | Full accounts made up to 31 December 2021 | |
| 07 Nov 2022 | CS01 | Confirmation statement made on 30 September 2022 with updates | |
| 23 Aug 2022 | AD01 | Registered office address changed from 85 Capital House King William Street London EC4N 7BL England to Capital House 85 King William Street London EC4N 7BL on 23 August 2022 | |
| 23 Aug 2022 | AD01 | Registered office address changed from One Glass Wharf Bristol BS2 0ZX United Kingdom to 85 Capital House King William Street London EC4N 7BL on 23 August 2022 | |
| 23 Aug 2022 | CERTNM |
Company name changed intercept pharma uk & ireland LTD\certificate issued on 23/08/22
|
|
| 08 Aug 2022 | AP01 | Appointment of Mr Simon Tucker as a director on 1 July 2022 | |
| 22 Jul 2022 | AD01 | Registered office address changed from Capital House 85 King William Street London EC4N 7BL England to One Glass Wharf Bristol BS2 0ZX on 22 July 2022 | |
| 05 Jul 2022 | AD01 | Registered office address changed from One Glass Wharf Bristol BS2 0ZX United Kingdom to Capital House 85 King William Street London EC4N 7BL on 5 July 2022 | |
| 04 Jul 2022 | PSC02 | Notification of Mercury Pharma Group Limited as a person with significant control on 1 July 2022 | |
| 04 Jul 2022 | PSC07 | Cessation of Intercept Pharmaceuticals, Inc. as a person with significant control on 1 July 2022 | |
| 04 Jul 2022 | AP01 | Appointment of Mr Francisco Javier Barcelo Sanchez as a director on 1 July 2022 | |
| 04 Jul 2022 | AP01 | Appointment of Mr Vikram Laxman Kamath as a director on 1 July 2022 |